Key Points Immuron receives U.S. Food and Drug administration (FDA) approval for IMM-529 Investigational New Drug (IND) ...

Clostridioides difficile (C. difficile or C. diff) is a type of bacteria that causes a range of gastrointestinal symptoms, from mild diarrhoea to life-threatening colitis. It affects the colon, which ...

Clostridioides difficile, a bacteria that creates inflammation of the colon and causes symptoms like infectious diarrhea, is of particular risk among hospitalized patients. Findings of a new Polish ...

Using real-world data, researchers evaluated the safety and effectiveness of fecal microbiota, live-jslm in preventing recurrent Clostridioides difficile infection.

Clostridioides difficile (C. difficile) infection (CDI) is a significant healthcare-associated infection, known for its high morbidity and mortality rates, especially in vulnerable populations. CDI ...

At the end of September 2021, Freda Pyles, a resident of rural Pennsylvania, began an antibiotic for a dental infection. That set off a 6-month battle with Clostridioides difficile, which was ...

A variety of symptoms can be experienced, from mild diarrhea to severe colon damage. In addition, the use of antibiotics is often associated with the development of C. difficile illness. This disease ...

Oral presentation highlights microbiome restoration through six months with REBYOTA from Phase 3b CDI-SCOPE trial -- New data from CDI-SCOPE evaluating the long-term safety of REBYOTA -- Retrospective ...

A TLANTA -- A tapered and pulsed course of vancomycin was not significantly better than a standard course of the drug for ...

Pfizer Inc said on Tuesday its vaccine to prevent infections from the clostridioides difficile bacteria failed to meet the main goal of a late-stage study. Adds details on vaccine, background March 1 ...

When I took antibiotics for a sinus infection, I began feeling weak and feverish, with diarrhea. I went to the ER and learned I had Clostridioides difficile, an infection in the large intestine. The ...